Pharmacokinetics of detomidine administered to horses at rest and after maximal exercise.

The research examines the impact of exercise on how the drug detomidine, used for sedation, is processed in Thoroughbred horses. The findings suggested that after intense exercise, the drug is distributed more widely in the horse’s body, resulting in a slower rate of elimination and lower peak concentrations in the blood.

Objective and Methods

• The objective of the study was to understand whether the pharmacokinetics, or how the body processes a drug, of detomidine is different when administered to horses during recovery from intense exercise compared to when at rest.
• Six Thoroughbred horses were first conditioned with exercise on a treadmill, running a simulated race at a speed resulting in 120% of their maximum oxygen consumption.
• One minute after the end of the exercise, each horse was given detomidine. This process was repeated with the same dose of the drug given to the same horses at least 14 days later while the horses were standing idle.

Sample Collection and Analysis

• Blood samples with added heparin were collected at various time intervals during both trials.
• The concentration of detomidine in the plasma was then measured using liquid chromatography-mass spectrometry, a laboratory process used for identifying and quantifying components in a sample.
• The gathered plasma concentration versus time data was analysed with nonlinear regression analysis, a statistical method used to model the relationship between a dependent variable and one or more independent variables.

Results

• The research revealed that after exercise, the initial plasma concentration of the drug was significantly lower, while the time for the drug to reach half its original concentration and the average residence time of the drug in the body were both significantly longer.
• The distribution volume of the drug was higher post exercise, although there was no significant difference in how fast the drug was cleared from the plasma between the two treatments.

Conclusions

• The study concluded that detomidine, when administered intravenously immediately after exercise, is more widely distributed throughout the body compared to when given at rest. This results in lower peak plasma concentrations and a slower rate of elimination.
• The implication of these findings is that a higher dose of detomidine may be needed to achieve the same effect in horses post-exercise as compared to at rest. Furthermore, subsequent doses needed to maintain the effect may be less frequent due to the drug’s slower elimination.